170 related articles for article (PubMed ID: 15654339)
1. The p53QS transactivation-deficient mutant shows stress-specific apoptotic activity and induces embryonic lethality.
Johnson TM; Hammond EM; Giaccia A; Attardi LD
Nat Genet; 2005 Feb; 37(2):145-52. PubMed ID: 15654339
[TBL] [Abstract][Full Text] [Related]
2. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
[TBL] [Abstract][Full Text] [Related]
3. Modulation of wild-type p53 activity by mutant p53 R273H depends on the p53 responsive element (p53RE). A comparative study between the p53REs of the MDM2, WAFI/Cip1 and Bax genes in the lung cancer environment. WAFI/Cip1 = WAF1/Cip1.
Zacharatos PV; Gorgoulis VG; Kotsinas A; Manolis EN; Liloglou T; Rassidakis AN; Kanavaros P; Field JD; Halazonetis T; Kittas C
Anticancer Res; 1999; 19(1A):579-87. PubMed ID: 10226602
[TBL] [Abstract][Full Text] [Related]
4. Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant.
Rowan S; Ludwig RL; Haupt Y; Bates S; Lu X; Oren M; Vousden KH
EMBO J; 1996 Feb; 15(4):827-38. PubMed ID: 8631304
[TBL] [Abstract][Full Text] [Related]
5. Switching mechanisms of cell death in mdm2- and mdm4-null mice by deletion of p53 downstream targets.
Chavez-Reyes A; Parant JM; Amelse LL; de Oca Luna RM; Korsmeyer SJ; Lozano G
Cancer Res; 2003 Dec; 63(24):8664-9. PubMed ID: 14695178
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific expression of p53(R172L) differentially regulates p21, Bax, and mdm2 to inhibit prostate cancer progression and prolong survival.
Hernandez I; Maddison LA; Wei Y; DeMayo F; Petras T; Li B; Gingrich JR; Rosen JM; Greenberg NM
Mol Cancer Res; 2003 Dec; 1(14):1036-47. PubMed ID: 14707287
[TBL] [Abstract][Full Text] [Related]
7. Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation.
Koumenis C; Alarcon R; Hammond E; Sutphin P; Hoffman W; Murphy M; Derr J; Taya Y; Lowe SW; Kastan M; Giaccia A
Mol Cell Biol; 2001 Feb; 21(4):1297-310. PubMed ID: 11158315
[TBL] [Abstract][Full Text] [Related]
8. Role of the ATPase domain of the Cockayne syndrome group B protein in UV induced apoptosis.
Balajee AS; Proietti De Santis L; Brosh RM; Selzer R; Bohr VA
Oncogene; 2000 Jan; 19(4):477-89. PubMed ID: 10698517
[TBL] [Abstract][Full Text] [Related]
9. The loss of mdm2 induces p53-mediated apoptosis.
de Rozieres S; Maya R; Oren M; Lozano G
Oncogene; 2000 Mar; 19(13):1691-7. PubMed ID: 10763826
[TBL] [Abstract][Full Text] [Related]
10. Identification of a tumor-derived p53 mutant with novel transactivating selectivity.
Pan Y; Haines DS
Oncogene; 2000 Jun; 19(27):3095-100. PubMed ID: 10871862
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis by the p53-273L (Arg --> Leu) mutant in HSC3 cells without transactivation of p21Waf1/Cip1/Sdi1 and bax.
Kaneuchi M; Yamashita T; Shindoh M; Segawa K; Takahashi S; Furuta I; Fujimoto S; Fujinaga K
Mol Carcinog; 1999 Sep; 26(1):44-52. PubMed ID: 10487521
[TBL] [Abstract][Full Text] [Related]
12. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
Crowe DL; Sinha UK
Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
[TBL] [Abstract][Full Text] [Related]
13. The p53 targets mdm2 and Fas are not required as mediators of apoptosis in vivo.
Reinke V; Lozano G
Oncogene; 1997 Sep; 15(13):1527-34. PubMed ID: 9380404
[TBL] [Abstract][Full Text] [Related]
14. p51A (TAp63gamma), a p53 homolog, accumulates in response to DNA damage for cell regulation.
Katoh I; Aisaki KI; Kurata SI; Ikawa S; Ikawa Y
Oncogene; 2000 Jun; 19(27):3126-30. PubMed ID: 10871867
[TBL] [Abstract][Full Text] [Related]
15. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
[TBL] [Abstract][Full Text] [Related]
16. Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations.
Delia D; Goi K; Mizutani S; Yamada T; Aiello A; Fontanella E; Lamorte G; Iwata S; Ishioka C; Krajewski S; Reed JC; Pierotti MA
Oncogene; 1997 May; 14(18):2137-47. PubMed ID: 9174049
[TBL] [Abstract][Full Text] [Related]
17. The potential tumor suppressor p73 differentially regulates cellular p53 target genes.
Zhu J; Jiang J; Zhou W; Chen X
Cancer Res; 1998 Nov; 58(22):5061-5. PubMed ID: 9823311
[TBL] [Abstract][Full Text] [Related]
18. Abrogation of p53-induced G1 arrest by the HPV 16 E7 protein does not inhibit p53-induced apoptosis.
Wang Y; Okan I; Pokrovskaja K; Wiman KG
Oncogene; 1996 Jun; 12(12):2731-5. PubMed ID: 8700534
[TBL] [Abstract][Full Text] [Related]
19. Induction of Mdm2 and enhancement of cell survival by bFGF.
Shaulian E; Resnitzky D; Shifman O; Blandino G; Amsterdam A; Yayon A; Oren M
Oncogene; 1997 Nov; 15(22):2717-25. PubMed ID: 9400998
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of functional inactivation of a Li-Fraumeni syndrome p53 that has a mutation outside of the DNA-binding domain.
Gu J; Kawai H; Wiederschain D; Yuan ZM
Cancer Res; 2001 Feb; 61(4):1741-6. PubMed ID: 11245491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
